📰 Peripheral Access Kit News
Page 3 - Peripheral Access Kit News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peripheral Access Kit. Real-time updates on events, politics, business and more.
November 1, 2023
Several analysts have recently updated their ratings and price targets for Silk Road Medical (NASDAQ: SILK): 10/24/2023 – Silk Road Medical was upgraded by analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating. 10/11/2023 – Silk Road Medical was downgraded by analysts at Citigroup Inc. from a “buy” rating to a […]
October 15, 2023
Silk Road Medical (NASDAQ:SILK – Free Report) had its price target cut by Piper Sandler from $25.00 to $11.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a neutral rating on the stock. Several other research analysts have also weighed in on the company. Stifel Nicolaus lowered Silk Road […]
October 11, 2023
-- Silk Road Medical has an average hold rating and price target range of $11 to $35, according to analysts polled by Capital IQ. Price: 6.74, Change: -7.25, Percent Change: -51.86 ...
October 11, 2023
-- Silk Road Medical shares sank 50% amid heavy trading after the company, late Tuesday, lowered its projections for full-year 2023 sales. Piper Sandler cut its price target for the companys...
October 2, 2023
Silk Road Medical, Inc (NASDAQ:SILK – Get Free Report) has earned a consensus rating of “Hold” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to […]
August 30, 2023
Silk Road Medical (NASDAQ:SILK – Get Free Report) and Insulet (NASDAQ:PODD – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Analyst Ratings This is a summary of current […]
August 9, 2023
Silk Road Medical, Inc (NASDAQ:SILK – Free Report) – Research analysts at B. Riley raised their Q3 2023 earnings per share estimates for Silk Road Medical in a note issued to investors on Wednesday, August 2nd. B. Riley analyst N. Chatterji now expects that the company will earn ($0.35) per share for the quarter, up […]
August 5, 2023
Silk Road Medical (NASDAQ:SILK – Free Report) had its price target cut by Stifel Nicolaus from $50.00 to $45.00 in a research report report published on Wednesday morning, Marketbeat.com reports. They currently have a buy rating on the stock. A number of other equities research analysts also recently weighed in on SILK. Piper Sandler lowered […]
August 2, 2023
Silk Road Medical (NASDAQ:SILK – Get Free Report) had its price target decreased by stock analysts at B. Riley from $58.00 to $54.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. B. Riley’s price target would indicate a potential upside of 144.68% […]
August 2, 2023
Silk Road Medical (NASDAQ:SILK – Get Free Report) had its target price reduced by research analysts at B. Riley from $58.00 to $54.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. B. Riley’s price target suggests a potential upside of 144.68% from the stock’s previous […]